Assessing expanded community wide treatment for schistosomiasis: Baseline infection status and self-reported risk factors in three communities from the Greater Accra region, Ghana.
Adolescent
Adult
Aged
Aged, 80 and over
Animals
Anthelmintics
/ administration & dosage
Child
Child, Preschool
Communicable Disease Control
/ methods
Demography
Disease Transmission, Infectious
/ prevention & control
Feces
/ parasitology
Ghana
/ epidemiology
Humans
Infant
Infant, Newborn
Longitudinal Studies
Male
Mass Drug Administration
/ methods
Middle Aged
Prevalence
Risk Factors
Schistosomiasis
/ epidemiology
Urine
/ parasitology
Young Adult
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
24
05
2019
accepted:
05
12
2019
revised:
07
05
2020
pubmed:
28
4
2020
medline:
2
7
2020
entrez:
28
4
2020
Statut:
epublish
Résumé
This paper reports on the baseline prevalence and associated risk factor findings of a pilot, longitudinal study exploring community-wide treatment of schistosomiasis and soil-transmitted helminthiasis, using albendazole plus praziquantel in the Greater Accra region of Ghana. From three communities, at least, 658 individuals were enrolled into the study via random household selection. Prevalence and intensity of schistosomiasis and STH infection were determined from stool and urine samples with a questionnaire being administered in order to explore other morbidities and risk factors. Factor analysis of household demographic variables was undertaken to generate a socioeconomic score; this was then further categorised into tertiles. Proportional-odds cumulative logit generalised estimating equation (GEE) models were used to investigate categorical ordinal intensity of infection associations with morbidity. Separately, logistic GEE models were used to investigate risk factor associations with infection prevalence. Both Schistosoma haematobium and S. mansoni were prevalent in the three communities, with the prevalence of S. haematobium ranging from 3.3% (24/679; 95% CI = 1.9-4.7) to 19% (114/632; 95% CI = 15.8-22.2) and S. mansoni ranging from 30% (202/679; 95% CI = 26.5-33.5) to 78.3% (409/536; 95% CI = 74.7-81.9). The total prevalence of STH across all three sites was negligible at 1.3% (24/1847; 95% CI = 0.8-1.9) comprising mainly hookworm (10/1847). Multivariable statistical models indicated males to be 2.3 (95% CI = 1.7-3.3) times more likely to have a high intensity S. mansoni infection and 1.5 (95% CI = 1.1-2) times more likely to have a high intensity of S. haematobium infection compared to females. There was no significant difference in the likelihood of infection with S. mansoni between adults and school age children (SAC), however S. haematobium infections were found to be 2.5 (95% CI = 1.8-3.5) times more likely to occur in school age children than in adults. Multivariable statistical models (adjusted for age and sex) indicated an association between schistosomiasis and a number of self-reported morbidity indicators (notably diarrhoea and blood in stool and urine). Low socio-economic status was also associated with SCH infection (OR: 2; 95% CI = 1.3-3.2). The communities targeted by this study showed a range of Schistosoma prevalence's of infection, from hypo-endemic through to meso-endemic and hyper-endemic. The prevalence of SCH across the different age groups in the study locations highlights the large number of individuals currently being left out of the standard morbidity control method of annual treatment of the SAC.
Sections du résumé
BACKGROUND
This paper reports on the baseline prevalence and associated risk factor findings of a pilot, longitudinal study exploring community-wide treatment of schistosomiasis and soil-transmitted helminthiasis, using albendazole plus praziquantel in the Greater Accra region of Ghana.
METHOD
From three communities, at least, 658 individuals were enrolled into the study via random household selection. Prevalence and intensity of schistosomiasis and STH infection were determined from stool and urine samples with a questionnaire being administered in order to explore other morbidities and risk factors. Factor analysis of household demographic variables was undertaken to generate a socioeconomic score; this was then further categorised into tertiles. Proportional-odds cumulative logit generalised estimating equation (GEE) models were used to investigate categorical ordinal intensity of infection associations with morbidity. Separately, logistic GEE models were used to investigate risk factor associations with infection prevalence.
RESULTS
Both Schistosoma haematobium and S. mansoni were prevalent in the three communities, with the prevalence of S. haematobium ranging from 3.3% (24/679; 95% CI = 1.9-4.7) to 19% (114/632; 95% CI = 15.8-22.2) and S. mansoni ranging from 30% (202/679; 95% CI = 26.5-33.5) to 78.3% (409/536; 95% CI = 74.7-81.9). The total prevalence of STH across all three sites was negligible at 1.3% (24/1847; 95% CI = 0.8-1.9) comprising mainly hookworm (10/1847). Multivariable statistical models indicated males to be 2.3 (95% CI = 1.7-3.3) times more likely to have a high intensity S. mansoni infection and 1.5 (95% CI = 1.1-2) times more likely to have a high intensity of S. haematobium infection compared to females. There was no significant difference in the likelihood of infection with S. mansoni between adults and school age children (SAC), however S. haematobium infections were found to be 2.5 (95% CI = 1.8-3.5) times more likely to occur in school age children than in adults. Multivariable statistical models (adjusted for age and sex) indicated an association between schistosomiasis and a number of self-reported morbidity indicators (notably diarrhoea and blood in stool and urine). Low socio-economic status was also associated with SCH infection (OR: 2; 95% CI = 1.3-3.2).
CONCLUSION
The communities targeted by this study showed a range of Schistosoma prevalence's of infection, from hypo-endemic through to meso-endemic and hyper-endemic. The prevalence of SCH across the different age groups in the study locations highlights the large number of individuals currently being left out of the standard morbidity control method of annual treatment of the SAC.
Identifiants
pubmed: 32339185
doi: 10.1371/journal.pntd.0007973
pii: PNTD-D-19-00851
pmc: PMC7205311
doi:
Substances chimiques
Anthelmintics
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0007973Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Infect Dis Poverty. 2017 Feb 20;6(1):42
pubmed: 28219412
Acta Trop. 2008 Jan;105(1):45-54
pubmed: 17996207
Clin Infect Dis. 2018 Jun 1;66(suppl_4):S245-S252
pubmed: 29860290
Trop Med Infect Dis. 2018 Jan 22;3(1):
pubmed: 30720777
Parasitol Today. 1998 Oct;14(10):428-34
pubmed: 17040835
Trop Med Int Health. 2007 Jun;12(6):709-23
pubmed: 17550468
Proc Natl Acad Sci U S A. 2006 May 2;103(18):6934-9
pubmed: 16632601
Matern Child Nutr. 2008 Apr;4 Suppl 1:118-236
pubmed: 18289159
Am J Trop Med Hyg. 2000 Feb;62(2 Suppl):88-99
pubmed: 10813505
PLoS Med. 2014 Mar 25;11(3):e1001620
pubmed: 24667810
Parasit Vectors. 2015 Nov 05;8:570
pubmed: 26542226
Bull World Health Organ. 1987;65(1):57-66
pubmed: 3107847
PLoS Negl Trop Dis. 2015 Aug 20;9(8):e0003897
pubmed: 26291538
BMC Infect Dis. 2006 Aug 23;6:134
pubmed: 16928276
Infect Agent Cancer. 2013 May 24;8(1):19
pubmed: 23705833
Wkly Epidemiol Rec. 2017 Dec 08;92(49):749-60
pubmed: 29218962
Braz J Infect Dis. 2015 Mar-Apr;19(2):196-205
pubmed: 25636189
Int J Parasitol. 2016 Jun;46(7):395-404
pubmed: 27063073
PLoS Negl Trop Dis. 2016 May 19;10(5):e0004566
pubmed: 27196100
Clin Infect Dis. 2008 Sep 15;47(6):775-82
pubmed: 18680415
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
Parasit Vectors. 2014 Feb 19;7:74
pubmed: 24552246
Acta Trop. 2010 Sep;115(3):212-9
pubmed: 20303925
Am J Trop Med Hyg. 2016 May 4;94(5):1040-4
pubmed: 26976893
Trends Parasitol. 2003 Dec;19(12):547-51
pubmed: 14642761
Rev Inst Med Trop Sao Paulo. 1991 Jan-Feb;33(1):12-7
pubmed: 1843390
PLoS Negl Trop Dis. 2018 Apr 26;12(4):e0006296
pubmed: 29698486
PLoS Negl Trop Dis. 2014 Oct 09;8(10):e3221
pubmed: 25299057
Trop Geogr Med. 1985 Dec;37(4):295-7
pubmed: 3938093
PLoS Negl Trop Dis. 2013;7(2):e2027
pubmed: 23469293
J Physiol. 1973 Apr;230(1):27P
pubmed: 4702431
J Helminthol. 2005 Sep;79(3):199-206
pubmed: 16153313
Int J Parasitol. 2016 Jun;46(7):385-8
pubmed: 26907938
PLoS Negl Trop Dis. 2009 May 26;3(5):e430
pubmed: 19479041
Parasitology. 1993;107 Suppl:S107-23
pubmed: 8115176
Trop Med Int Health. 1998 Sep;3(9):711-20
pubmed: 9754666
Trans R Soc Trop Med Hyg. 2016 Dec;110(10):597-603
pubmed: 27864517
PLoS Negl Trop Dis. 2018 Aug 2;12(8):e0006563
pubmed: 30071014
Trans R Soc Trop Med Hyg. 1997 Nov-Dec;91(6):643-6
pubmed: 9509169
Nature. 1991 Jun 27;351(6329):757-9
pubmed: 1905786
Infect Dis Poverty. 2017 Nov 20;6(1):158
pubmed: 29151362
Parasitology. 1992 Oct;105 ( Pt 2):219-27
pubmed: 1454421
PLoS Negl Trop Dis. 2013;7(3):e2051
pubmed: 23505584
Trends Parasitol. 2016 Feb;32(2):97-107
pubmed: 26795294
Am J Trop Med Hyg. 2010 Nov;83(5):1048-55
pubmed: 21036836
PLoS Negl Trop Dis. 2017 Feb 8;11(2):e0005342
pubmed: 28178325
Acta Trop. 2003 Mar;85(3):339-47
pubmed: 12659971
Philos Trans R Soc Lond B Biol Sci. 2014 May 12;369(1645):20130435
pubmed: 24821921
Trop Med Int Health. 1997 Dec;2(12):1180-9
pubmed: 9438475
Clin Microbiol Rev. 2015 Oct;28(4):939-67
pubmed: 26224883
World Health Organ Tech Rep Ser. 2002;912:i-vi, 1-57, back cover
pubmed: 12592987
Parasit Vectors. 2017 Apr 28;10(1):213
pubmed: 28454578
Acta Trop. 2011 Sep;120 Suppl 1:S142-50
pubmed: 21195046
Parasit Vectors. 2017 Apr 19;10(1):192
pubmed: 28424091
Int J Parasitol. 2016 Nov;46(12):771-779
pubmed: 27616734